Symphony Pharmaceuticals

Symphony Pharmaceuticals was a private U.S. biopharmaceutical company founded in 1991 in Malvern, Pennsylvania. Historical reports describe the company as focused on discovering and developing drugs to regulate ion currents in the brain, and later biographies of founder Maria-Luisa Maccecchini refer to the business as Symphony Pharmaceuticals/Annovis with a focus on protecting brain cells after stroke. The company appears to have remained private, raised venture financing, and was sold to Transgenomic in 2001. Publicly available information on its historical pipeline is sparse, and no active operating business under this legacy biotech entity is evident today. The requested name also matches an unrelated active Indian domestic pharma marketer, but this record reflects the exact historical U.S. biotech company most clearly documented in biotech sources.